Inverness Medical Innovations, Inc.
Global leader in rapid point-of-care diagnostics and health management services, including home pregnancy and fertility tests (Clearblue), infectious disease, cardiology, and drugs-of-abuse testing.
Series B Convertible Perpetual Preferred Stock — Acquired by Abbott (via Alere) in 2017
No insider transactions reported in the last year. Look across all recorded history →